Objective: Critical limb ischemia remains a difficult disease to treat, with limited level 1 data. The Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial is attempting to answer whether initial treatment with surgical bypass or endovascular therapy improves outcomes. Although still in the enrollment phase, this study aims to compare amputation-free survival (AFS) and reintervention in patients treated with initial open surgical bypass or endovascular intervention for ischemic ulcers of the lower extremities.
Northwell Health System, New York, NY Objective: Drug-eluting stents (DESs) are highly efficacious for interventions on coronary saphenous vein graft bypasses, with improved patency over angioplasty and bare-metal stenting. We have used these stents in failing lower extremity bypass grafts with aggressive or refractory stenotic lesions and present the experience at a single institution.
Methods: All patients who underwent DES (coronary stent) placement in an infrainguinal vein bypass graft from 2012 to 2017 were identified through operative records. Demographic, treatment, and follow-up data were extracted retrospectively from the medical record. Wilcoxon signed rank and rank sum tests were used to compare the reintervention-free intervals for paired and unpaired data, respectively.
Results: A total of 22 DESs were placed in 18 lower extremities. Median age at the time of bypass was 64 years (range, 49-84 years). All patients required an infrageniculate distal anastomosis, and great saphenous vein was used. After bypass, patients underwent a mean of 3.3 6 2.4 interventions. Fortyfive percent of reinterventions were for recurrent ischemic symptoms (n ¼ 27); 55% were reintervened on for asymptomatic but concerning surveillance duplex ultrasound findings. Reinterventions included plain balloon angioplasty (percutaneous transluminal angioplasty [PTA] , n ¼ 27), drugcoated balloon angioplasty (n ¼ 6), cutting balloon angioplasty (n ¼ 5), bare-metal stenting (n ¼ 8), and DES placement. DESs were placed for initial (n ¼ 13) or recurrent (n ¼ 9) stenoses. Half of all DESs were placed immediately after PTA that had yielded unsatisfactory residual stenosis on completion angiography. All attempted DES placements were technically successful and required no additional interventions at time of placement. The median time to reintervention or time to last available duplex ultrasound examination demonstrating patency (if no additional reintervention occurred) trended in favor of DES (7.7 months; interquartile range [IQR], 3.7-13.8 months) over standard endovascular interventions (4.8 months; IQR, 1.8-9.7 months; P ¼ .22) but was not statistically significant. On subgroup analysis of patients with DES placed for a recurrent stenosis after a preceding standard endovascular intervention (n ¼ 9 stents), time to reintervention was significantly longer after DES compared with that of the preceding standard intervention (median, 7.1 months [IQR, Conclusions: DES provided acceptable durability for lower extremity bypass stenoses and was a helpful adjunct for patients with unacceptable immediate post-PTA stenosis on completion angiography. Furthermore, in the subgroup of patients with DES placed for recurrent stenosis after standard interventions, DES had significantly increased durability compared with those standard interventions. Objectives: Patients with critical limb ischemia (CLI) face barriers to care, including coordinating travel required for multiple care visits. We aimed to investigate perceptions and attitudes of patients with CLI to sharing health information through images, text, and video encounters with their vascular surgeon.
Methods: Inpatients treated for Rutherford Class 5 and 6 ischemia underwent semistructured interviews focused on sharing pictures, communicating with a provider by internet, willingness use photo/text through a portable device, and video consultation for evaluation of their limb wound. Using mixed-methods, responses were coded and themes were developed from interview transcripts. Themes where aggregated into assertions for use of telemedicine in CLI.
Results: Ten patients with a mean age of 69 years (range, 37-79 years) were interviewed. All patients lived with either a partner or an adult child at a distance ranging from 10 to 90 minutes away. Level of education ranged from some high school to some college and all patients reported an annual household income less than $50,000. All patients had the ability to send text/photos to their provider, although three patients would need a spouse or child to help. Nine patients would want additional training prior to sending a photo or communicating with a provider through a portable device. Privacy concerns were limited, but two patients already using the secure electronic health platform would prefer to use it vs simple text. Eight patients expressed a lack of trust if they were required to communicate photos/text questions with an unknown provider. Patients perceived a benefit of using video consultation for the evaluation of their wound, including saving time, money, and distance of travel. However, all 10 patients would prefer to be seen in person for the initial consultation and use video-based imaging only for secondary visits. The main assertion for use of video consultation was that patients did not feel they could establish a connection and develop trust with a provider they did not meet in person.
Conclusions: In this exploratory study, patients with CLI felt that with specific training, they could communicate with their provider through portable technology. Despite this, patients still prefer to come into the clinic, even when it was inconvenient, in order to establish a patient doctor relationship. For providers establishing a telemedicine program, specific focus must be given to the development of this relationship in the video consultation.
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Objective: Diabetic patients exhibit distinct patterns of diffuse and recalcitrant peripheral artery disease, which subsequently predisposes them to poor wound healing, infection, and critical limb ischemia. Fatty acid synthase (FAS), an enzyme responsible for de novo fatty acid synthesis, exhibits elevated content in the liver tissue in diabetic mouse models and elevated serum levels in diabetic patients with carotid artery stenosis. It is currently unknown whether tissue FAS and serum circulating FAS (cFAS) correlate with diabetic status in patients with femoral arterial occlusive disease.
Methods: To evaluate this, we enrolled diabetic and nondiabetic patients undergoing femoral endarterectomy in an Institutional Review Board-approved vascular biobank. Fasting serum and femoral endarterectomy plaque samples were collected from participants, and tissue FAS and serum cFAS content and enzymatic activity were evaluated using enzyme-linked immunosorbent assay. Differences in cFAS content and activity between cohorts were summarized as mean 6 standard error of the mean, and statistical significance was determined using t-test and Pearson correlation analysis. 
